Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Perspectives
Increasing Focus on Value Related to Cancer Drugs: A Payer Perspective
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Breast Cancer
Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
Lowell L Hart, MD
Read More
Perspectives
The Importance of Patient Education: A Nurse’s Perspective
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Read More
Perspectives
Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective
Val R. Adams, PharmD, FCCP, BCOP
,
Allison R. Butts, PharmD, BCOP
Read More
Results 1 - 4 of 4
